MedTrace Logo

Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer

NCT00946543 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

PURPOSE: This phase I trial is studying the best dose of intensity-modulated radiation therapy in treating patients with prostate cancer.

Conditions

Interventions

RADIATION

hypofractionated radiation therapy

RADIATION

intensity-modulated radiation therapy

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • David P. Dearnaley, MD, FRCP, FRCR · Royal Marsden NHS Foundation Trust

Study Design

Purpose
TREATMENT

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2010-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946543 on ClinicalTrials.gov